SCHEMBL5000185

SCHEMBL5000185

CCCCCCCc1ccc(-c2nccc(-c3cc4n(n3)CCNC4=O)n2)cc1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CDC7 O00311 2/20 0.46
MAPT P10636 3/20 0.39
MEN1 O00255 2/20 0.39
ALDH1A1 P00352 2/20 0.39
KMT2A Q03164 2/20 0.39
KDM4E B2RXH2 1/20 0.39
USP2 O75604 1/20 0.39
GAA P10253 1/20 0.39
HPGD P15428 1/20 0.39
RAB9A P51151 1/20 0.39
SMN1; SMN2 Q16637 1/20 0.39
HSD17B10 Q99714 1/20 0.39
IKBKB O14920 1/20 0.38
CHUK O15111 1/20 0.38
RARB P10826 5/20 0.36
SPHK2 Q9NRA0 4/20 0.36
RARA P10276 1/20 0.36
MTOR P42345 1/20 0.36
PIM1 P11309 1/20 0.35
PIM2 Q9P1W9 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4991440 1.00 CDC7 (0.46) CDC7MAPTMEN1ALDH1A1KMT2A
SCHEMBL4997371 1.00 CDC7 (0.46) CDC7MAPTMEN1ALDH1A1KMT2A
SCHEMBL14188559 0.99 CDC7 (0.45) CDC7MAPTMEN1ALDH1A1KMT2A
SCHEMBL14188503 0.99 CDC7 (0.45) CDC7MAPTMEN1ALDH1A1KMT2A
SCHEMBL4994742 0.99 CDC7 (0.46) CDC7MAPTMEN1ALDH1A1KMT2A
SCHEMBL4996096 0.98 CDC7 (0.46) CDC7MAPTMEN1ALDH1A1KMT2A
SCHEMBL5002853 0.96 CDC7 (0.47) CDC7MAPTMEN1ALDH1A1KMT2A
SCHEMBL14188564 0.95 CDC7 (0.46) CDC7MAPTMEN1ALDH1A1KMT2A
SCHEMBL4996911 0.92 CDC7 (0.49) CDC7MEN1KMT2AKDM4EGAA
SCHEMBL5002863 0.91 CDC7 (0.48) CDC7MEN1KMT2AKDM4EGAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20080113971-A1 PYRAZOLE COMPOUNDS AS PROTEIN KINASE INHIBITORS HANAU CATHLEEN E 2008-05-15 US disclosed
US-20080113971-A1 PYRAZOLE COMPOUNDS AS PROTEIN KINASE INHIBITORS HANAU CATHLEEN E 2008-05-15 US disclosed
US-20080113971-A1 PYRAZOLE COMPOUNDS AS PROTEIN KINASE INHIBITORS HANAU CATHLEEN E 2008-05-15 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080113971-A1 PYRAZOLE COMPOUNDS AS PROTEIN KINASE INHIBITORS MKNK2, MAPKAPK2, MAP3K2 CDC7 487/4885MAPT 1363/4885MEN1 2627/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.